Having a large clinical trial portfolio means giving patients treatment options often not available anywhere else, and years before they become the standard of care. To learn more about Karmanos Cancer Institute clinical trials or to see if a trial is right for you, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment below
Back to Results

  • A phase I/II study of disappearing markers for daily radiation treatment delivery

    Cancer Categories
    • Breast
    Karmanos Trial ID
    • 2025-034
    NCT ID
    • NCT07095114
    Age Group
    • Adult
    Scope
    • Local
    PhaseClick for Clinical Trial Phase DefinitionPhase I
    Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
    • Phase I/II
    Principal Investigator

    Objective:

    Primary Objective:

    • The primary objective of the study is to test the hypothesis that tattoos applied using Magic Ink will be just as safe as those made with a commercially available standard tattoo ink for the purpose of RT.

    Secondary Objective:

    • The secondary objective of this study will verify that Magic Ink continues to function and remain adequately visible for radiation therapists to effectively use the tattoos as landmark guidance throughout standard RT.
    Request an Appointment
    Refer a Patient
    NCI Dictionary of Cancer Terms
    KCI Clinical Trials App
    • Locations

    Locations

    Karmanos Cancer Institute - Detroit Headquarters

    4100 John R
    Detroit, MI 48201
    Get Directions
    Phone: 1-800-527-6266